AbCellera Biologics Inc. announced that at its AGM held on June 13, 2024, the shareholders approved the election of Andrew Lo, Ph.D. as Class I directors of the company to serve for a three-year term expiring at the company?s annual meeting of shareholders in 2027 and until his or her successor has been elected and qualified.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.925 USD | +1.56% | +1.38% | -48.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.51% | 847M | |
+39.19% | 39.1B | |
-8.03% | 38.76B | |
+27.44% | 31.24B | |
+12.60% | 25.9B | |
-13.75% | 25.8B | |
+45.89% | 14.06B | |
+39.78% | 13.12B | |
-6.57% | 11.32B | |
-12.06% | 10.68B |
- Stock Market
- Equities
- ABCL Stock
- News AbCellera Biologics Inc.
- AbCellera Biologics Inc. Approves Election of Andrew Lo as Class I Director